September 2019

In January 2018, we announced the validation of a new model of atopic dermatitis in mice.  Now that we have 18 months' experience of using it, here's our feedback. Back in January 2018, we announced the validation of a new model of atopic dermatitis in mice using topical applications of 2,4-Dinitrochlorobenzene (DNCB) over a period of 5 weeks in Balb/c mice (Newsletter #1). This validation allowed us to show that the model reproduces the essential characteristics of human pathology, and in